Co-Amoxiclav
Co-amoxiclav is a combination of Amoxicillin and Potassium Clavulanate (clavulanic acid) indicated in the treatment of infections due to susceptible isolates of the designated bacteria.
- Description
Description
Co-amoxiclav is a combination of Amoxicillin and Potassium Clavulanate (clavulanic acid) indicated in the treatment of infections due to susceptible isolates of the designated bacteria.
Indication:
- LRTIs such as tonsillitis and sinusitis.
- Otitis media.
- URTIs such as broncho and lobar-pneumonia, acute and chronic bronchitis.
- UTIs such as female genital infections, cystitis, urethritis and pyelonephritis.
- Skin and soft tissue infections.
- Pre and post-operative infections.
- Gonorrheal infections.
Amoxicillin component of the formulation exerts a bactericidal action against many strains of gram-positive and gram- negative organisms.
Clavulanic acid causes inactivation of susceptible beta-lactamase which protects amoxicillin from degradation by beta –lactamase enzymes produced by penicillin resistant strains of bacteria.
| FEATURES | BENEFITS |
| High clearance rate of bacteria load. | Reduces the chance of relapse. |
| Rapidly effective. | High cure rate. |
| Cost-effective. | Affordable to patient. |
Dosage:
Co-amoxiclav 1g: 1 table twice daily.
Co-amoxiclav 625mg: 1 tablet twice daily.
Co-amoxiclav 228.5ml: Depends on body weight.